Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol. / Vik, Ingvild; Bollestad, Marianne; Grude, Nils; Baerheim, Anders; Mölstad, Sigvard; Bjerrum, Lars; Lindbaek, Morten.

I: BMC Infectious Diseases, Vol. 14, 693, 2014.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

Vik, Ingvild ; Bollestad, Marianne ; Grude, Nils ; Baerheim, Anders ; Mölstad, Sigvard ; Bjerrum, Lars ; Lindbaek, Morten. / Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol. I: BMC Infectious Diseases. 2014 ; Vol. 14.

RIS

TY - JOUR

T1 - Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol

AU - Vik, Ingvild

AU - Bollestad, Marianne

AU - Grude, Nils

AU - Baerheim, Anders

AU - Mölstad, Sigvard

AU - Bjerrum, Lars

AU - Lindbaek, Morten

PY - 2014

Y1 - 2014

N2 - Background: Although uncomplicated cystitis is often self-limiting, most such patients will be prescribed antibiotic treatment. We are investigating whether treatment of cystitis with an NSAID is as effective as an antibiotic in achieving symptomatic resolution. Methods/Design: This is a randomized, controlled, double blind trial following the principles of Good Clinical Practice. Women between the ages of 18 to 60 presenting with symptoms of uncomplicated cystitis are screened for eligibility. 500 women from four sites in Norway, Sweden and Denmark are allocated to treatment with 600 mg ibuprofen three times a day or 200 mg mecillinam three times a day for three days. Allocation is conducted using block randomization. The primary outcome is the number of patients who feel cured by day four as recorded in a diary. Adverse events will be handled and reported in accordance with Good Clinical Practice. Discussion: If treatment of uncomplicated cystitis with ibuprofen is as effective as mecillinam for symptom relief, we can potentially reduce the use of antibiotics on a global scale.

AB - Background: Although uncomplicated cystitis is often self-limiting, most such patients will be prescribed antibiotic treatment. We are investigating whether treatment of cystitis with an NSAID is as effective as an antibiotic in achieving symptomatic resolution. Methods/Design: This is a randomized, controlled, double blind trial following the principles of Good Clinical Practice. Women between the ages of 18 to 60 presenting with symptoms of uncomplicated cystitis are screened for eligibility. 500 women from four sites in Norway, Sweden and Denmark are allocated to treatment with 600 mg ibuprofen three times a day or 200 mg mecillinam three times a day for three days. Allocation is conducted using block randomization. The primary outcome is the number of patients who feel cured by day four as recorded in a diary. Adverse events will be handled and reported in accordance with Good Clinical Practice. Discussion: If treatment of uncomplicated cystitis with ibuprofen is as effective as mecillinam for symptom relief, we can potentially reduce the use of antibiotics on a global scale.

KW - Cystitis

KW - NSAID

KW - Antibiotics

KW - Ibuprofen

KW - Mecillinam

KW - General practice

U2 - 10.1186/s12879-014-0693-y

DO - 10.1186/s12879-014-0693-y

M3 - Article

VL - 14

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

M1 - 693

ER -